The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 10, 2018
Filed:
Feb. 06, 2014
Sanofi Pasteur, Lyons, FR;
Imperial Innovations Limited, London, GB;
Gary McLean, London, GB;
Walton Ross, Stratford upon Avon Warwickshire, GB;
Sebastian Johnston, London, GB;
Nathan Wylie Bartlett, Newcastle, GB;
Bruno Guy, Lyons, FR;
Yves Girerd-Chambaz, Messimy, FR;
Valerie Lecouturier, Chazay d'Azergues, FR;
Jeffrey Almond, Reading, GB;
Nicholas Glanville, London, GB;
Nicolas Burdin, Saint Genis les Ollieres, FR;
Other;
Abstract
The present invention concerns: a) an isolated peptide comprising an amino acid sequence which is at least 90% identical to the VP4 amino acid sequence of a rhinovirus, or an isolated polynucleotide comprising a nucleic acid sequence encoding said peptide, placed under the control of the elements necessary for its expression in a mammalian cell; and/or b) an isolated peptide comprising an amino acid sequence of at least 100 amino acids which is at least 90% identical to an amino acid sequence located in the last 363 C-terminal amino acids of the RNA polymerase of a rhinovirus, or an isolated polynucleotide comprising a nucleic acid sequence encoding said peptide, placed under the control of the elements necessary for its expression in a mammalian cell; and c) a Th1 adjuvant when said immunogenic composition comprises one or more of said isolated peptides.